224 related articles for article (PubMed ID: 29733583)
21. Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues.
Ellison M; Feng ZP; Park AJ; Zhang X; Olivera BM; McIntosh JM; Norton RS
J Mol Biol; 2008 Apr; 377(4):1216-27. PubMed ID: 18295795
[TBL] [Abstract][Full Text] [Related]
22. Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins.
Cuny H; Kompella SN; Tae HS; Yu R; Adams DJ
J Biol Chem; 2016 Nov; 291(45):23779-23792. PubMed ID: 27646000
[TBL] [Abstract][Full Text] [Related]
23. d-Amino Acid Substitution of α-Conotoxin RgIA Identifies its Critical Residues and Improves the Enzymatic Stability.
Ren J; Zhu X; Xu P; Li R; Fu Y; Dong S; Zhangsun D; Wu Y; Luo S
Mar Drugs; 2019 Feb; 17(3):. PubMed ID: 30823399
[TBL] [Abstract][Full Text] [Related]
24. Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor.
Yu R; Kompella SN; Adams DJ; Craik DJ; Kaas Q
J Med Chem; 2013 May; 56(9):3557-67. PubMed ID: 23566299
[TBL] [Abstract][Full Text] [Related]
25. Development of Conformationally Constrained α-RgIA Analogues as Stable Peptide Antagonists of Human α9α10 Nicotinic Acetylcholine Receptors.
Zheng N; Christensen SB; Blakely A; Dowell C; Purushottam L; McIntosh JM; Chou DH
J Med Chem; 2020 Aug; 63(15):8380-8387. PubMed ID: 32597184
[TBL] [Abstract][Full Text] [Related]
26. Alanine-Scanning Mutagenesis of α-Conotoxin GI Reveals the Residues Crucial for Activity at the Muscle Acetylcholine Receptor.
Ning J; Li R; Ren J; Zhangsun D; Zhu X; Wu Y; Luo S
Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30551685
[TBL] [Abstract][Full Text] [Related]
27. Molecular interaction of α-conotoxin RgIA with the rat α9α10 nicotinic acetylcholine receptor.
Azam L; Papakyriakou A; Zouridakis M; Giastas P; Tzartos SJ; McIntosh JM
Mol Pharmacol; 2015 May; 87(5):855-64. PubMed ID: 25740413
[TBL] [Abstract][Full Text] [Related]
28. Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.
Luo S; Zhangsun D; Harvey PJ; Kaas Q; Wu Y; Zhu X; Hu Y; Li X; Tsetlin VI; Christensen S; Romero HK; McIntyre M; Dowell C; Baxter JC; Elmslie KS; Craik DJ; McIntosh JM
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4026-35. PubMed ID: 26170295
[TBL] [Abstract][Full Text] [Related]
29. Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins?
Nevin ST; Clark RJ; Klimis H; Christie MJ; Craik DJ; Adams DJ
Mol Pharmacol; 2007 Dec; 72(6):1406-10. PubMed ID: 17804600
[TBL] [Abstract][Full Text] [Related]
30. Structure-Activity Studies Reveal the Molecular Basis for GABA
Sadeghi M; Carstens BB; Callaghan BP; Daniel JT; Tae HS; O'Donnell T; Castro J; Brierley SM; Adams DJ; Craik DJ; Clark RJ
ACS Chem Biol; 2018 Jun; 13(6):1577-1587. PubMed ID: 29746088
[TBL] [Abstract][Full Text] [Related]
31. Interaction of α9α10 Nicotinic Receptors With Peptides and Proteins From Animal Venoms.
Tsetlin V; Haufe Y; Safronova V; Serov D; Shadamarshan P; Son L; Shelukhina I; Kudryavtsev D; Kryukova E; Kasheverov I; Nicke A; Utkin Y
Front Cell Neurosci; 2021; 15():765541. PubMed ID: 35002625
[TBL] [Abstract][Full Text] [Related]
32. Alpha9 nicotinic acetylcholine receptors and the treatment of pain.
McIntosh JM; Absalom N; Chebib M; Elgoyhen AB; Vincler M
Biochem Pharmacol; 2009 Oct; 78(7):693-702. PubMed ID: 19477168
[TBL] [Abstract][Full Text] [Related]
33. The Structural Features of α-Conotoxin Specifically Target Different Isoforms of Nicotinic Acetylcholine Receptors.
Wu RJ; Wang L; Xiang H
Curr Top Med Chem; 2015; 16(2):156-69. PubMed ID: 26126912
[TBL] [Abstract][Full Text] [Related]
34. α-Conotoxin [S9A]TxID Potently Discriminates between α3β4 and α6/α3β4 Nicotinic Acetylcholine Receptors.
Wu Y; Zhangsun D; Zhu X; Kaas Q; Zhangsun M; Harvey PJ; Craik DJ; McIntosh JM; Luo S
J Med Chem; 2017 Jul; 60(13):5826-5833. PubMed ID: 28603989
[TBL] [Abstract][Full Text] [Related]
35. Solving the alpha-conotoxin folding problem: efficient selenium-directed on-resin generation of more potent and stable nicotinic acetylcholine receptor antagonists.
Muttenthaler M; Nevin ST; Grishin AA; Ngo ST; Choy PT; Daly NL; Hu SH; Armishaw CJ; Wang CI; Lewis RJ; Martin JL; Noakes PG; Craik DJ; Adams DJ; Alewood PF
J Am Chem Soc; 2010 Mar; 132(10):3514-22. PubMed ID: 20163143
[TBL] [Abstract][Full Text] [Related]
36. Dicarba α-conotoxin Vc1.1 analogues with differential selectivity for nicotinic acetylcholine and GABAB receptors.
van Lierop BJ; Robinson SD; Kompella SN; Belgi A; McArthur JR; Hung A; MacRaild CA; Adams DJ; Norton RS; Robinson AJ
ACS Chem Biol; 2013 Aug; 8(8):1815-21. PubMed ID: 23768016
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of Action and Structure-Activity Relationship of α-Conotoxin Mr1.1 at the Human α9α10 Nicotinic Acetylcholine Receptor.
Liang J; Tae HS; Zhao Z; Li X; Zhang J; Chen S; Jiang T; Adams DJ; Yu R
J Med Chem; 2022 Dec; 65(24):16204-16217. PubMed ID: 36137181
[TBL] [Abstract][Full Text] [Related]
38. The α9α10 nicotinic acetylcholine receptors antagonist α-conotoxin RgIA reverses colitis signs in murine dextran sodium sulfate model.
AlSharari SD; Toma W; Mahmood HM; Michael McIntosh J; Imad Damaj M
Eur J Pharmacol; 2020 Sep; 883():173320. PubMed ID: 32645334
[TBL] [Abstract][Full Text] [Related]
39. Computational and Functional Mapping of Human and Rat α6β4 Nicotinic Acetylcholine Receptors Reveals Species-Specific Ligand-Binding Motifs.
Hone AJ; Kaas Q; Kearns I; Hararah F; Gajewiak J; Christensen S; Craik DJ; McIntosh JM
J Med Chem; 2021 Feb; 64(3):1685-1700. PubMed ID: 33523678
[TBL] [Abstract][Full Text] [Related]
40. Effect of Methionine Oxidation and Substitution of α-Conotoxin TxID on α3β4 Nicotinic Acetylcholine Receptor.
Ren J; Li R; Ning J; Zhu X; Zhangsun D; Wu Y; Luo S
Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29925760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
